Prognostic impact of blood and urinary angiogenic factor levels at diagnosis and during treatment in patients with osteosarcoma: a prospective study

BACKGROUND: Angiogenesis is essential for the progression and metastatic spread of solid tumours. Expression of vascular endothelial growth factor (VEGF) has been linked to poor survival among osteosarcoma patients but the clinical relevance of monitoring blood and urine angiogenic factors is uncert...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:BMC Cancer
Auteurs principaux: Tabone, Marie-Dominique, Brugières, Laurence, Piperno-Neumann, Sophie, Selva, Marie-Ange, Marec-Bérard, Perrine, Pacquement, Hélène, Lervat, Cyril, Corradini, Nadège, Gentet, Jean-Claude, Couderc, Rémy, Chevance, Aurélie, Mahier-Ait Oukhatar, Céline, Entz-Werle, Natacha, Blay, Jean-Yves, Le Deley, Marie-Cecile
Format: Artigo
Langue:Inglês
Publié: BioMed Central 2017
Sujets:
Research Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5473001/
https://ncbi.nlm.nih.gov/pubmed/28619014
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-017-3409-z
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires